Found 57 matching trials
Iressa Expanded Access Program (EAP) PHASE3 A program for patients with non small cell lung cancer who may benefit from...
Show More Learn More & Join Trial
Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy PHASE3 Pemetrexed was known to be effective to pulmonary adenocarcinoma and gefiti...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer PHASE2 The aim of the study is to estimate the effect of preoperative gefitinib on...
Show More Learn More & Join Trial
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer PHASE1 RATIONALE: Gefitinib may stop the growth of tumor cells by blocking the enz...
Show More Location
Tower Cancer Research Foundation
Learn More & Join Trial
Bioequivalence Study of Gefitinib Tablets Under Fed Conditions PHASE1 The study design is an Open-Label,Randomized, Single-Dose, 2-way Crossover ...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck PHASE2 The purpose of this study is to demonstrate the activity (response rate and...
Show More Location
University of Miami Sylvester Comprehensive Cancer Center
Learn More & Join Trial
PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC) N/A The objective of this pharmacoeconomics (PE) study is to evaluate the cost-...
Show More Location
Department of Oncology, National Taiwan University Hospital
Learn More & Join Trial
A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer PHASE1 During Phase 1b portion, there will be a dose-escalation of AV-299 (formerl...
Show More Location
Investigational Site 1
Learn More & Join Trial
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung PHASE2 This is a randomised, open-label, phase IIb trial of afatinib to compare to...
Show More Location
Chris Obrien Lifehouse
Learn More & Join Trial
Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer PHASE1 RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, work in differe...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial